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INTRODUCTION
Cyclosporine A (CsA) is a widely used immunosuppressant,
with clinical applications ranging from organ transplants to
chronic inflammatory diseases. One of the major side effects
associated with CsA treatment is the development of gingi-
val overgrowth (GO) (1-3). Regarding the histology of CsA-
induced GO, the exuberant growth of connective tissue by
active fibroblasts within the periodontium is the most com-
mon feature, and a case of extramedullary plasmacytoma as
well as squamous cell carcinoma and Kaposi’s sarcoma has
been previously reported (4). To our knowledge, there has
been no case of gingival plasma cell granuloma in renal trans-
plant recipients treated with CsA as one of immunosuppres-
sive agents. 
Several studies have suggested that one of the pathogenic
mechanisms underlying drug-induced GO may be the en-
hanced secretion of interleukin-6 (IL-6) in response to the im-
munosuppressive medications, such as CsA (5, 6). A recent
report demonstrated that CsA upregulated phospholipase
C- 1 (PLC- 1) in fibroblasts from GO (7). However, data
concerning the molecular mechanisms involved in the patho-
logic connective tissue proliferation are as yet preliminary in
nature. 
We here report two patients who developed plasma cell
granuloma of the gingiva 12 months and 8 yr after combined
treatment with CsA and prednisolone for renal transplanta-
tion with immunohistochemical studies for IL-6 and PLC- 1.
CASE REPORT
Clinical history
Case 1: A 62-yr-old male patient with an end stage renal
disease due to diabetic nephropathy underwent renal trans-
plantation in July 1998 and then was treated with CsA and
prednisolone. One year later, he complained of gingival en-
largement with bleeding.
Case 2: A 59-yr-old female patient presented with a diffuse
gingival swelling, which had gradually increased for two
years. She complained of difficulty in mastication, which
was associated with gingival hyperplasia. She had underwent
renal transplantation in April 1990 and was treated with CsA
and prednisolone. She had one episode of acute rejection in
1991, which was treated with a high dose of CsA and pred-
nisolone. 
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Plasma Cell Granuloma in Cyclosporine-Induced Gingival Overgrowth
: A Report of Two Cases with Immunohistochemical Positivity of Interleukin-6 and
Phospholipase C- 1 
We report two cases of gingival plasma cell granuloma in a 34-yr-old and 40-yr-
old two male renal transplant recipients with cyclosporine A (CsA)-induced gin-
gival overgrowth (GO). Histologically, these lesions were composed of mature
plasma cells, showing polyclonality for both lambda and kappa light chains and
fibrovascular connective tissue stroma. In addition to the fact that CsA-induced
plasma cell granuloma is rare, the salient features of our cases were the secre-
tion of interleukin-6 and overexpression of phospholipase C- 1 of the tumor cells,
which may explain the mechanisms of CsA- induced GO.
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Pathologic findings
On dental examination, two patients were revealed to have
marked generalized GO and underwent gingivectomy with
gingivoplasty. The gross specimen from the gingiva consist-
ed of a pinkish yellow fibro-connective tissue covered with
mucosal epithelium, measuring 3.5 cm in its greatest dimen-
sion. Cut-section showed a homogeneous and granular sur-
face. 
Tissue sections showed hypertrophic squamous epithelium
and underlying cellular lesion composed mostly of mature
plasma cells and intervening fibrous connective tissue with
Fig. 1. Microscopic findings. (A) a low power view of gingival biopsy specimen shows diffuse infiltration of plasma cells in fibrotic stroma
with overlying squamous epithelium (H&E,×100). (B) a high power view of Fig. 1A reveals that the infiltrating plasma cells are all mature
forms and do not show any pleomorphism (H&E,×400).
A B
Fig. 2. Immunhistochemistry for IL-6 demonstrated that plasma
cells, endothelial cells, and fibroblasts are diffusely positive in
their cytoplasms (×200).
Fig. 3. PLC- 1 immunoreactivity is positive in the cytoplasms of
most plasma cells (immunostain for PLC- 1,×200) and smooth
muscle  cells of the vascular wall (internal staining).706 S.S. Kim, D. Eom, J. Huh, et al.
blood vessels (Fig. 1A). The individual plasma cells had eccen-
tric round nuclei with cartwheel chromatin pattern and abun-
dant cytoplasm (Fig. 1B). There was no nuclear atypia or pleo-
morphism. Mitotic figures were not observed. Cytoplasms of
some plasma cells contained immunoglobulin-like globules.
The covering epithelium showed slight hyperplasia. Neither
ulceration nor atypical proliferation was observed. Increased
fibrosis with fibroblast activation was not remarkable. Immu-
nophenotyping revealed polyclonality for both lambda and
kappa light chains (data not shown). Stainings of these cells
for panT, panB, CD68, CD15, and CD30 were negative.
These immunohenotyping findings confirmed the light mi-
croscopic interpretation of plasma cell granuloma composed
of mature plasma cells. Cytokeratin staining showed strong
positivity on the squamous epithelium. 
Immunohistochemistry for IL-6 and PLC- 1
Antibodies for IL-6 (8) and PLC- 1 (9) used in this study.
Most infiltrating plasma cells showed strong expression of
IL-6 in their cytoplasms (Fig. 2). Beside the tumor cells, en-
dothelial cells and fibroblasts were also positive for IL-6, even
if less intense. The PLC- 1 was diffusely positive in plasma
cells and stromal cells (Fig. 3). We also did an immunohis-
tochemical study for PLC- 1, but the plasma cells and fibrob-
lasts were negative for this isozyme in tissue section (data not
shown).
DISCUSSION
Gingival overgrowth is a well-documented unwanted side
effect associated with phenytoin, cyclosporine, and the cal-
cium channel blockers (1-3). The present cases showed pro-
found and diffuse mature plasma cell infiltration in addition
to the fibroblast proliferation with fibrosis, which was rather
less prominent. Even if CsA-induced GO is almost always
associated with acute or chronic inflammation due to plaque
accumulation, triggering the secretion of inflammatory cyto-
kines (5, 6) and mediators, the present case showed unique
findings. Among the previous reports of CsA-induced GO,
only one case reported the primary extramedullary plasma-
cytoma with favorable prognosis. Therefore, it seems that a
careful differential diagnosis from malignant plasmacytoma
was needed in our cases (4). However, as described in micro-
scopic findings, the infiltrating plasma cells were almost fully
mature and showed obvious polyclonality for lambda and
kappa light chains by immunohistochemistry, which could
differentiate the plasma cells from these of malignant plas-
macytoma. 
Although the pathogenesis of drug-induced GO is uncer-
tain, it has been postulated that CsA alters the fibroblast acti-
vity through effects on various growth factors and cytokines,
such as PDGF- (platelet-derived growth factor - ) (10, 11)
and IL-6 (5, 6). IL-6 is known to not only mediate important
signals in the nonspecific gingival inflammation, but also
play an important role in the pathogenesis of CsA-induced
GO. Both the present two cases revealed strong immunore-
activity for IL-6 in the cytoplasms of plasma cells, as well as
endothelial cells and fibroblasts. This finding suggests that
CsA does regulate the cytokine expression in gingival tissue,
and this effect may play an important role in the pathogen-
esis of CsA-induced GO, along with its well-established effect
on T cells (4). Considering that multiple myelomas are asso-
ciated with high levels of IL-6, IL-6 plays an important role
in the differentiation and activation of plasma cells as well
as other stages of B cells (8). IL-6, secreted by gingival tis-
sue due to CsA stimulation, may induce heavy plasma cell
infiltration, as in our cases and in the previously document-
ed case of plasmacytoma (5). 
One of the interesting findings in our cases is the overex-
pression of PLC- 1 in plasma cells of the gingival tissues.
PLC- 1 is involved in cell proliferation via various growth
factors, signaling pathways, including that of PDGF (12) as
has been, demonstrated in several cancer tissues. Plemons et
al. (10) demonstrated CsA-induced GO is associated with the
enhanced expression of the macrophage PDGF- gene. The
fact that PDGF is related with PLC- 1 signaling pathway
may support our hypothesis that PLC- 1 is involved in CsA-
induced GO. Although a previous study suggested that
cAMP/protein kinase A might be involved in IL-6 produc-
tion by human gingival fibroblasts (5), recent observation
showed that tyrosine phosphorylation of PLC- 1 is induced
by IL-6 in PC 12 cells (13). The elucidation of exact role of
and relation between IL-6 and PLC- 1 needs further experi-
ments. A recent report demonstrated that CsA upregulated
nuclear PLC- 1 in fibroblasts from GO (7). In the present
cases, neither plasma cells nor fibroblasts expressed PLC- 1.
The possible explanations for the discrepancy between our
result and that of Breschi et al. (7) include the differences of
the materials (tissues vs cells) and antibodies used, and the
major component (plasma cells vs fibroblasts). 
Our observation suggests that IL-6 and PLC- 1 may induce
heavy plasma cells infiltration in CsA-induced GO. Consid-
ering the increased levels of IL-6 and PLC- 1 in plasma cells,
understanding of the roles of IL-6 and PLC- 1 in CsA-induced
GO can be of great implication in designing future therapies
aimed at the prevention of GO after cyclosporine treatment
for immune suppression in transplant recipients.
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